New pill shows promise for arthritis sufferers
NCT ID NCT06800157
First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 23 times
Summary
This study tested a new tablet called LW402 in 72 adults with moderate to severe rheumatoid arthritis who were already taking methotrexate. The goal was to see if adding LW402 for 12 weeks could reduce joint pain and swelling better than a placebo. The trial is complete, and results will show how well the drug works and if it is safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTHRITIS, RHEUMATOID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100730, China
Conditions
Explore the condition pages connected to this study.